Oncotarget Plasma Growth Hormone in HCC: A Biomarker of Response to Atezo/Bev? In a new study, researchers investigated the plasma growth hormone as a potential biomarker of... read more December 8, 2022
Oncotarget Biomarkers May Predict Neoadjuvant Chemosensitivity in Bladder Cancer In a new study, researchers aimed to identify and validate predictive biomarkers of response to... read more November 15, 2022
Oncotarget Protein-Based Risk Model Predicts Esophageal Cancer Recurrence Researchers developed a multi-protein expression-based risk model to predict recurrence-free survival for ESCC patients.The... read more September 23, 2022
Oncotarget How Heartburn Can Turn Into Esophageal Cancer, and a Possible Biomarker In a recent Oncotarget paper, researchers investigated telomere shortening in patients with Barrett's esophagus as... read more July 15, 2022
Oncotarget Biomarker Predicts Treatment Efficacy in Triple-Negative Breast Cancer In this 2020 paper, researchers searched for biomarkers of sacituzumab govitecan treatment efficacy in triple-negative... read more July 27, 2021
Oncotarget Trending With Impact: Novel Biomarkers in Bladder Cancer Researchers from the University of Houston and UT Southwestern Medical Center conducted a study which... read more June 3, 2021
Oncotarget A New Potential Network of Biomarkers Useful Across Sarcomas Researchers examined five potential prognostic and therapeutic biomarkers across 18 different histologic subtypes of sarcoma... read more April 14, 2021
Oncotarget First Blood Test for Early Melanoma Detection (A 2018 Study) In this widely-read Oncotarget paper from 2018, Australian researchers developed the first blood test to... read more April 6, 2021